Group One Trading’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Group One Trading’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,800	Closed	-$1.24K	–	8692
2023 Q2	$1.24K	Buy	+1,800	New	+$11.6K	﹤0.01%	7219

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Group One Trading's BLPH Position: Q4 2023 in Review

Group One Trading sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 2,100 shares — an estimated $840 sold.

Group One Trading first reported a position in BLPH in Q2 2023 and held it in 2 quarters. The position peaked at $2.69K in Q2 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

Group One Trading reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 2,100 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $840.
Group One Trading first reported a position in Bellerophon Therapeutics, Inc. in Q2 2023 and held it in 2 quarters.
Group One Trading's Bellerophon Therapeutics, Inc. position peaked at $2.69K in Q2 2023.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.